Peptidyl-lysine deacetylation

pathway activity — cross-omics
GO:0034983Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-lysine deacetylation pathway is significantly associated with the RNA expression of multiple genes, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FBXO40, MOSPD2, and GCC2, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine deacetylation activity versus FBXO40 in CCRCC (Pearson r = 0.01).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCFBXO40 →+0.091+0.229.006.00233
GBMMOSPD2 →+0.325+0.620.005.00133
HNSCGCC2 →+0.506+0.820.001.00133
HNSCEFHD1 →+0.578+0.724.005<.00133
HNSCCCN2 →+1.106+0.867.004<.00133
HNSCSMIM4 →+0.578+1.019<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0034983 vs FBXO40 — CCRCC

Per-sample scatter of Peptidyl-lysine deacetylation activity vs FBXO40 in CCRCC.

Explore this scatter interactively →

Exploration